{"authors": [["Gil Campos", "Mercedes", "M", ". mercedes_gil_campos@yahoo.es."], ["Blasco-Alonso", "Javier", "J", null], ["Sierra C\u00f3rcoles", "Concepci\u00f3n", "C", null], ["Cuevas Cervera", "Jos\u00e9 Luis", "JL", null], ["Arrabal Fern\u00e1ndez", "Luisa", "L", null], ["Ald\u00e1miz Echevarr\u00eda", "Luis", "L", null], ["Belanger", "Amaya", "A", null]], "date": "2017-07-28", "id": "29095003", "text": "The hyperammonemic encephalopathy induced by causes different from inborn errors of metabolism is a relatively uncommon but severe complication.To study the characteristics of a secondary hyperammonemia episode to discern the triggering causes to get to the diagnosis, and the development in the therapeutic intervention.A multicenter retrospective study of children with hyperammonemia unrelated to inborn errors of metabolism, conducted in Spanish hospitals.Nineteen patients were selected; hyperammonemia developed in infants under one year old in 47% of them, being diagnosed mostly with two or more symptoms. The most common clinical finding was an altered consciousness level similar to that of intoxication symptoms, followed by seizures. These clinical symptoms were present in 14 patients, with one of them or both. Twelve of the 19 patients were in treatment with more than two antiepileptic drugs routinely. All children were treated with protein restriction (n: 10), scavengers (n: 10) and/or carglumic acid (n: 12) for the treatment of hyperammonemia.This study suggests that secondary hyperammonemia could be underdiagnosed because it is only detected when severe symptoms appear. Risk seems to be higher in those patients receiving antiepileptic drugs or those critically ill with a restricted diet or incremented metabolism. The response to specific treatment is adequate but should be established earlier to avoid neurological sequelae of this entity.INTRODUCCI\u00d3N: la encefalopat\u00eda hiperamoni\u00e9mica inducida por causas diferentes a los errores innatos del metabolismo es una complicaci\u00f3n relativamente infrecuente, pero muy grave. OBJETIVOS: conocer las caracter\u00edsticas de un episodio de hiperamoniemia secundaria, tratar de discernir las causas desencadenantes, c\u00f3mo se llega al diagn\u00f3stico del episodio y c\u00f3mo se desarrolla la actuaci\u00f3n terap\u00e9utica. M\u00c9TODOS: es un estudio multic\u00e9ntrico retrospectivo de casos pedi\u00e1tricos con hiperamoniemia no relacionada con errores innatos del metabolismo, llevado a cabo en hospitales espa\u00f1oles.\u00a0RESULTADOS: fueron seleccionados 19 pacientes y en un 47% el episodio de hiperamoniemia apareci\u00f3 en menores de un a\u00f1o, que fueron diagnosticados mayoritariamente con dos o m\u00e1s s\u00edntomas. La cl\u00ednica m\u00e1s frecuente fue la de alteraci\u00f3n del nivel de conciencia tipo intoxicaci\u00f3n, seguida de las crisis convulsivas, sumando en ambas hasta 14 pacientes con alguna de ellas o las dos. Doce de los 19 pacientes utilizaban m\u00e1s de dos f\u00e1rmacos antiepil\u00e9pticos de forma habitual. Todos los ni\u00f1os recibieron tratamiento con restricci\u00f3n proteica (n: 10), quelantes (n: 10) y/o \u00e1cido cargl\u00famico (n: 12) para el tratamiento de la hiperamoniemia. CONCLUSIONES: este estudio sugiere que la hiperamoniemia secundaria puede estar infradiagnosticada y solo se detecta cuando aparece una sintomatolog\u00eda grave. Parecen ser pacientes de riesgo aquellos que reciben f\u00e1rmacos antiepil\u00e9pticos o aquellos cr\u00edticos con una alimentaci\u00f3n restringida o un metabolismo elevado. La respuesta con tratamiento espec\u00edfico es adecuada pero debe ser precoz para evitar las secuelas neurol\u00f3gicas de esta entidad.", "doi": null, "title": "[Spanish multicenter study: hyperammonemia not associated with inborn errors of metabolism in children].", "journal": ["Nutricion hospitalaria", "Nutr Hosp"]}